“…Currently, the genes BMP4 (bone morphogenetic protein 4; Miyazaki et al, 2000;Hoshino et al, 2008;Weber et al, 2008a;Chi et al, 2011;Paces-Fessy et al, 2012;Dos Reis et al, 2014), AGTR2 (angiotensin II receptor type 2; Nishimura et al, 1999;Oshima et al, 2001;Nakanishi and Yoshikawa, 2003;Hahn et al, 2005;Miranda et al, 2014), PAX2 (paired box gene 2; Dressler et al, 1993;Nakanishi and Yoshikawa, 2003;Dziarmaga et al, 2006;Chen et al, 2008;Harshman and Brophy, 2012;de Miranda et al, 2014), SIX1 (Ruf et al, 2004), SIX5 (Hoskins et al, 2007), GDNF (glial cell line-derived neurotrophic factor), RET (Rearranged during Tranfection), WNT (wingless-type MMTV integration site family), SALL (Spalt-like transcription factor; Nishinakamura et al, 2001;Nishinakamura and Takasato, 2005), EYA1 (Eyes Absent 1; Abdelhak et al, 1997), TCF2 (transcription factor 2; Weber et al, 2006;Decramer et al, 2007), and others are believed to play a role in the pathogenesis of human CAKUT, as shown in Table 1. Possibly, the failure of signaling events elicited by these genes at specified times results in diverse phenotypes of CAKUT (Sax en and Sariola, 1987;Dressler et al, 1990;Nishimura et al, 1999;Ichikawa et al, 2002;Kuwayama et al, 2002;Yosypiv, 2012Yosypiv, , 2008Marrone and Ho, 2014).…”